GGrantIndex
← Leaderboards

Aikaterini Kontrogianni-Konstantopoulos

University Of Maryland Baltimore

$13,265,718
Attributed
$16,410,306
Total exposure
8
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.1M · FY200625
$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$16,410,306 · 8

By mechanism

R01$12,210,502 · 5
T32$3,413,414 · 1
R21$786,390 · 2

Top collaborators

Most similar at University Of Maryland Baltimore

Same institution · by research overlap

Others in their field

Top investigators on “In Vivo

Research focus

In VivoProteinsGenesAffectObscurinSignal TransductionMolecularBiologyIn VitroMediatingProtein IsoformsCytoskeletal ProteinsFamilyStriated MusclesMuscleBindingPhosphorylationPropertyMembranePlayStructureLinkCytoskeletonMutate

Grant awards (42)

Obscurin-kinase 1/N-cadherin: a new signaling axis in cardiac structure/function$560,597
R01 · FY2025 · HL · contact PI
Interdisciplinary Training Program in Muscle Biology$481,440
T32 · FY2025 · AR · contact PI
Obscurin-kinase 1/N-cadherin: a new signaling axis in cardiac structure/function$56,369
R01 · FY2025 · HL · contact PI
Obscurin-kinase 1/N-cadherin: a new signaling axis in cardiac structure/function$545,239
R01 · FY2024 · HL · contact PI
Cytoskeletal Regulation of SERCA in Muscle$544,263
R01 · FY2024 · AR
Novel MYBPC1 mutations cosegregate with a myopathy associated with muscle weakness, hypotonia and tremor$399,601
R01 · FY2024 · AR · contact PI
Interdisciplinary Training Program in Muscle Biology$290,339
T32 · FY2024 · AR · contact PI
Obscurin-kinase 1/N-cadherin: a new signaling axis in cardiac structure/function$56,369
R01 · FY2024 · HL · contact PI
Obscurin-kinase 1/N-cadherin: a new signaling axis in cardiac structure/function$18,758
R01 · FY2024 · HL · contact PI
Obscurin-kinase 1/N-cadherin: a new signaling axis in cardiac structure/function$638,438
R01 · FY2023 · HL · contact PI
Cytoskeletal Regulation of SERCA in Muscle$561,096
R01 · FY2023 · AR
Interdisciplinary Training Program in Muscle Biology$519,089
T32 · FY2023 · AR · contact PI
Novel MYBPC1 mutations cosegregate with a myopathy associated with muscle weakness, hypotonia and tremor$411,960
R01 · FY2023 · AR · contact PI
Obscurin-kinase 1/N-cadherin: a new signaling axis in cardiac structure/function$584,784
R01 · FY2022 · HL · contact PI
Cytoskeletal Regulation of SERCA in Muscle$555,485
R01 · FY2022 · AR
Interdisciplinary Training Program in Muscle Biology$508,999
T32 · FY2022 · AR · contact PI
Novel MYBPC1 mutations cosegregate with a myopathy associated with muscle weakness, hypotonia and tremor$407,841
R01 · FY2022 · AR · contact PI
Cytoskeletal Regulation of SERCA in Muscle$544,263
R01 · FY2021 · AR
Interdisciplinary Training Program in Muscle Biology$479,398
T32 · FY2021 · AR · contact PI
Novel MYBPC1 mutations cosegregate with a myopathy associated with muscle weakness, hypotonia and tremor$399,600
R01 · FY2021 · AR · contact PI
Interdisciplinary Training Program in Muscle Biology$620,385
T32 · FY2020 · AR · contact PI
Cytoskeletal Regulation of SERCA in Muscle$561,096
R01 · FY2020 · AR
Novel MYBPC1 mutations cosegregate with a myopathy associated with muscle weakness, hypotonia and tremor$425,655
R01 · FY2020 · AR · contact PI
Development of high throughput screening technologies in breast cancer$630,575
R01 · FY2019 · CA
Interdisciplinary Training Program in Muscle Biology$513,764
T32 · FY2019 · AR · contact PI
Regulation of MyBP-C slow via phosphorylation in skeletal muscles$169,950
R21 · FY2019 · AR · contact PI
Development of high throughput screening technologies in breast cancer$11,746
R01 · FY2019 · CA
Development of high throughput screening technologies in breast cancer$715,272
R01 · FY2018 · CA
Regulation of MyBP-C slow via phosphorylation in skeletal muscles$203,940
R21 · FY2018 · AR · contact PI
Development of high throughput screening technologies in breast cancer$63,307
R01 · FY2018 · CA
Development of high throughput screening technologies in breast cancer$653,902
R01 · FY2017 · CA
Development of high throughput screening technologies in breast cancer$66,763
R01 · FY2017 · CA
Development of high throughput screening technologies in breast cancer$655,669
R01 · FY2016 · CA
Development of high throughput screening technologies in breast cancer$54,570
R01 · FY2016 · CA
Development of high throughput screening technologies in breast cancer$671,169
R01 · FY2015 · CA
HAX-1: a Multifaceted Family of Apoptotic Regulators$187,500
R21 · FY2012 · HL · contact PI
HAX-1: a Multifaceted Family of Apoptotic Regulators$225,000
R21 · FY2011 · HL · contact PI
M-Line Proteins and A-Band Assembly in Skeletal Muscle$276,996
R01 · FY2010 · AR · contact PI
M-Line Proteins and A-Band Assembly in Skeletal Muscle$279,793
R01 · FY2009 · AR · contact PI
M-Line Proteins and A-Band Assembly in Skeletal Muscle$279,793
R01 · FY2008 · AR · contact PI
M-Line Proteins and A-Band Assembly in Skeletal Muscle$285,503
R01 · FY2007 · AR · contact PI
M-Line Proteins and A-Band Assembly in Skeletal Muscle$294,030
R01 · FY2006 · AR · contact PI